Video

MDS and AML Biology

Author(s):

Aplastic Anemia,MDS International Foundation

Dr. Timothy Graubert, Massachusetts General Hospital and Dr. Stephanie Halene, Yale University School of Medicine discuss the highlights of their session on the Biology of Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.

Dr. Timothy Graubert, Massachusetts General Hospital and Dr. Stephanie Halene, Yale University School of Medicine discuss the highlights of their session on the Biology of Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.

Related Videos
Related Content
Reblozyl is a ‘Better First-Line Therapy’ for Anemia in MDS Subset
September 19th 2023

Reblozyl is a ‘Better First-Line Therapy’ for Anemia in MDS Subset

Ashley Chan
Reblozyl for anemia in patients with an MDS subset demonstrated positive effects, compared with previous treatments, according to an MDS expert.
AAMDS Upcoming Events: March 2022
February 16th 2022

AAMDS Upcoming Events: March 2022

AAMDSIF hosts Patient & Family Conferences around the United States each year.
AAMDS Upcoming October 2021 Events
September 15th 2021

AAMDS Upcoming October 2021 Events

Learn more about upcoming October events from the Aplastic Anemia and MDS International Foundation.
AAMDS Upcoming Events
August 31st 2021

AAMDS Upcoming Events

Learn more about upcoming events from the Aplastic Anemia and MDS International Foundation.
Site Logo
July 22nd 2019

AAMDSIF Upcoming Webinars: August 2019

AAMDSIF
The Aplastic Anemia and MDS International Foundation presents webinars for patients and their loved ones at no charge to participants.
Site Logo
June 25th 2019

AAMDSIF Presents First Lifetime Achievement in Science Award to Dr. Mary Horowitz

Aplastic Anemia & MDS International Foundation
The Aplastic Anemia & MDS International Foundation presented its first Lifetime Achievement in Science Award to Mary Horowitz, MD, MS at the Foundation’s 35th Anniversary Luncheon and Awards Program on May 18, 2019. Dr. Horowitz was honored for the significant impact her work has had on stem cell transplant and hematologic malignancy practice worldwide.